Erythromycin ethylsuccinate
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Erythromycin Ethylsuccinate is an antibiotic used to treat bacterial infections. It's available as an oral suspension in strengths like 200 mg or 400 mg per 5 mL, packaged in 100 mL bottles. Manufactured by Cadila Pharmaceuticals Limited and Nivagen Pharmaceuticals, Inc., it's a prescription drug approved under ANDA216212. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Erythromycin ethylsuccinate
Access the FDA dataset for Erythromycin ethylsuccinate โ ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025